Gottardi CJ, Gumbiner BM.

R37 GM374432 NIGMS NIH HHS , E.0865 Telethon

	Figure 1. Wnt signaling generates a form of β-catenin that binds preferentially to TCF-GST compared with cadherin-GST. (A) Detergent-free supernatants were prepared from C57MG and Rat1 cells stably expressing Wnt-1, and HEK293T cells incubated overnight ± Wnt3a-conditioned media (CM). Samples were affinity precipitated using equimolar amounts of cad-GST or TCF-GST fusion proteins. GST gives no binding and is not depicted. A fivefold excess of parental cell lysates was required to detect a signal in lanes 5 and 6. Cytosolic β-catenin from C57MG parentals binds cad-GST and TCF-GST proteins equivalently, like the Rat1 and HEK293 controls (not depicted). The blot was probed with a pAb to β-catenin. (B) Preferential binding of β-catenin to TCF-GST over cadherin-GST is not observed with purified, recombinant β-catenin. Recombinant, purified Xenopus β-catenin (Suh and Gumbiner, 2003) and β-catenin from a C57MG/Wnt cytosolic fraction were affinity precipitated with cad-GST and TCF-GST proteins, and blotted with an antibody to β-catenin.
	Figure 2. The COOH terminus of β-catenin restricts binding to cadherin. COOH terminus of β-catenin competes cadherin, but not TCF binding. (A) Schematic shows where α-catenin, cadherin, and TCF interact with β-catenin (Huber et al., 1997; Graham et al., 2000; Pokutta and Weis, 2000; Huber and Weis, 2001). (B) The COOH terminus of β-catenin binds the arm repeat region of β-catenin in yeast-two hybrid (Cox et al., 1999) and recombinant protein assays (Piedra et al., 2001). (C) COOH-terminal region of β-catenin competes β-catenin binding to cad-GST, but not to TCF-GST fusion protein. Recombinant β-catenin (1.5 μg) purified from baculovirus (Suh and Gumbiner, 2003) was incubated with cadherin-GST (2 μg) or TCF-GST (2.4 μg) coupled agarose beads in the presence of increasing amounts of β-catenin COOH-terminal peptide (amino acids 695–781). Affinity precipitates were analyzed by SDS-PAGE and Western blotting with an antibody to β-catenin. (D) Cadherin-GST preferentially depletes the fraction of β-catenin recognized by a COOH-terminal mAb (M5.2). A cytosolic fraction from Rat1/Wnt cells was affinity precipitated (×3) with cadherin-GST (lanes 1–3). The cad-GST nonbinding pool (lanes 4 and 5) was divided in two and immunoprecipitated with either an mAb that recognizes a COOH-terminal β-catenin epitope (βC-mAb (M5.2), lane 4) or an NH2-terminal β-catenin epitope (βN-mAb (1.1), lane 5). As a control, these antibodies were used to immunoprecipitate β-catenin from the total starting material (not previously depleted with cad-GST; lanes 6 and 7).
	Figure 3. Differential binding activity of recombinant β-catenin as revealed by deletion analysis. (A) Schematic representation of β-catenin constructs. WT-myc-Xenopus β-catenin and GSK3β mutant (S/T>A residues 33, 37, 41, and 45) β-catenin were described previously by Guger and Gumbiner (2000). WT-human β-catenin-flag, ΔC695-flag and ΔN89-flag constructs were described in Kolligs et al. (1999). The myc-tagged, Xenopus β-catenin construct encoding only the arm repeat region of β-catenin was described previously (Funayama et al., 1995). (B) Recombinant β-catenin binding to cad-GST versus TCF-GST proteins. HEK293T cells were transfected with decreasing amounts of β-catenin plasmid and incubated in the presence (+) of Wnt3a conditioned media (CM). Cytosolic fractions were affinity precipitated and immunoblotted with anti-myc, -flag, or β-catenin antibodies. Input amounts of wild-type β-catenin, −ΔC695, and arm 12 constructs were the same in accordance with similar expression levels (not depicted).
	Figure 4. Larger molecular size, α-catenin–containing fractions of β-catenin show preferential binding to cad-GST. (A) A cytosolic fraction from stage 12 Xenopus embryos was applied to a Sephacryl 300 gel filtration column, and fractions 28–39 were divided in two: one half of each sample was TCA-precipitated (top blot), whereas the other half was precipitated with cad-GST (middle blot). The top blot was reprobed with an antibody to α-catenin and is shown below. (B) Same as A except that starting material is an S100 fraction from Rat1/Wnt cells. Arrows refer to elution volumes of standard proteins with known molecular weight: (a) catalase (Mr = 232,000); (b) BSA (Mr = 66,000), purified mouse IgG (150 kD) eluted in fractions 31–33.
	Figure 5. The α-catenin–free, monomeric form of β-catenin exhibits preferential binding to TCF compared with cadherin in Wnt cells. (A) Rat1 cells were labeled to steady-state with [35S]methionine/cysteine, and a cytosolic fraction was prepared from each condition (−Wnt, +Wnt, 10 mM LiCl, 12 h) and immunoprecipitated with the designated antibodies or affinity precipitated with GST proteins. Note that immunoprecipitation of endogenous E-cadherin (from the 100,000 g membrane pellet, lanes 5, 10, and 16) and TCF (lane 11) are also shown. Non-specific bands were not seen with a GST control (not depicted). Overnight incubation with LiCl (10 mM) allows the α-catenin–free pool of β-catenin to bind cad-GST, TCF-GST, and the endogenous E-cadherin (lanes 14–16), equivalently. (B). COOH-terminal epitopes of β-catenin are masked in the α-catenin–free fraction of β-catenin. Equivalent amounts of an S100 fraction from [35S]methionine/cysteine steady-state–labeled Rat1+Wnt cells were immunoprecipitated with the following antibodies: anti–β-catenin NH2-terminal mAb (1.1.1; lane 1), anti–β-catenin COOH-terminal mAb (M5.2; lane 2), anti–α-catenin mAb (lane 4), and a nonimmune control (lane 3). (Lanes 5–7) PDZ protein, mLin7, preferentially binds to β-catenin–α-catenin dimer: metabolically labeled Rat1+Wnt lysates were affinity precipitated with (lane 5) anti–β-catenin pAb, (lane 6) control GST, and (lane 7) mLin7-GST.
	Figure 6. β-Catenin binding selectivity as a function of APC mutant status or GSK inhibition by LiCl. (A) A cytosolic fraction was prepared from colon carcinoma cell lines containing wild-type (HCT116) or mutant (HT29 and DLD1) forms of APC. (B) Selective binding activity of β-catenin in response to short-term, but not long-term treatment with LiCl. HEK293T cells were treated with 10 mM LiCl for 3, 6, and 15 h, after which cytosolic fractions were affinity precipitated as described above.
	Figure 7. β-Catenin not phosphorylated at NH2-terminal GSK-3β sites binds to cadherin. (A) Cytosolic fraction from HEK293 cells ± Wnt3a was affinity precipitated with cad-GST and TCF-GST, and blotted with pAbs to β-catenin (top blot) or NH2-terminal unphosphorylated–β-catenin (amino acids 27–37, bottom blot). (B) NH2-terminal unphospho–β-catenin localizes to sites of cell–cell contact in Wnt-expressing cells. Rat1 fibroblasts ± Wnt were fixed and processed for immunofluorescence using standard protocols. Images were captured with the Axioplan 2 microscope and AxioVision2.0 software (Carl Zeiss MicroImaging, Inc.). Note that membrane staining of the unphospho-β-catenin (Cy3) is more readily detected under methanol, rather than PFA fixation conditions, perhaps accounting for the apparent differences observed between our study and Staal et al. (2002).
	Figure 8. Cadherin phosphorylation reverses β-catenin binding selectivity during Wnt signaling. (A) Phosphorylation of cad-GST increases β-catenin binding to cadherin compared with TCF. A cytosolic fraction from L cells transfected with Wnt3a were incubated with equimolar amounts of cad-GST, TCF-GST, and CK2-P-cad-GST-glutathione–coupled beads for 1 h at 4°C (see Fig. S1 for characterization of GST fusion proteins). The resulting anti–β-catenin and anti-GST immunoblots are shown. (B) Fraction of β-catenin that binds cadherin is a subset of fraction of β-catenin that binds TCF. Cytosolic fraction of Wnt cells was sequentially affinity precipitated with cad-GST (lanes 1–3) or TCF-GST (lanes 6–8) proteins. After cad-GST depletion (lanes 1–3), half of the cad-GST non-binding fraction (NB/2) was precipitated with TCF-GST (lane 4); the other half was precipitated with TCA to show amount remaining (lane 5, far right). After TCF-GST depletion (lanes 6–8), half of the TCF-GST non-binding fraction (NB/2, lane 9) was precipitated with cad-GST, whereas the other half was precipitated with TCA to show amount remaining (lane 10, far right). Lanes 5 and 10 reveal a fraction of β-catenin that binds neither TCF nor cadherin. This fraction is likely due to β-catenin already complexed with partners such as ICAT (Gottardi and Gumbiner, 2004). (C) Phosphorylated cadherin-GST and TCF-GST bind the same pool of β-catenin in Wnt-activated cells. Cytosolic fraction was precipitated with cad-GST (top blot), TCF-GST (bottom left) or P-cadherin-GST (bottom right) fusion proteins. After cad-GST depletion (lanes 2–4 and 7–9), there is a fraction of β-catenin that binds TCF-GST (lane 5) and P-cadherin-GST (lane 10). Note that after TCF-GST depletion (lanes 13–15), there is no β-catenin remaining to bind P-cadherin-GST (lane 16). After P-cadherin-GST depletion (lanes 18–20), there is no β-catenin remaining to bind TCF-GST (lane 21). Reciprocal depletions suggest that P-cadherin-GST and TCF-GST bind the same form of β-catenin.
	Figure 9. Multiple forms of β-catenin exist in cells. NH2-terminal phospho-β-catenin is well characterized and generated by the APC-Axin-GSK3β-CK1 complex (dashed line). Closed form of β-catenin is generated by Wnt signaling, perhaps through some of the same machinery (gray arrow). β-Catenin–α-catenin dimer is active for adhesion but not signaling. Open form binds both cadherin and TCF, and could explain how cadherin antagonizes β-catenin signaling in overexpression systems. The inactive form cannot participate in adhesion or signaling.

Barker, The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. 2001, Pubmed

Barker, The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. 2001, Pubmed
Bradley, Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion. 1993, Pubmed
Bullions, Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities. 1997, Pubmed
Caca, Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. 1999, Pubmed
Castaño, Beta-catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin. 2002, Pubmed
Cox, Roles of the C terminus of Armadillo in Wingless signaling in Drosophila. 1999, Pubmed , Xenbase
Cox, Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. 1996, Pubmed
Fagotto, Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. 1996, Pubmed , Xenbase
Funayama, Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. 1995, Pubmed , Xenbase
Giannini, alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex. 2000, Pubmed
Gottardi, Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. 2004, Pubmed
Gottardi, E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. 2001, Pubmed
Gottardi, Adhesion signaling: how beta-catenin interacts with its partners. 2001, Pubmed
Graham, Crystal structure of a beta-catenin/Tcf complex. 2000, Pubmed , Xenbase
Guger, A mode of regulation of beta-catenin signaling activity in Xenopus embryos independent of its levels. 2000, Pubmed , Xenbase
Gumbiner, Regulation of cadherin adhesive activity. 2000, Pubmed
Hamada, A Drosophila APC tumour suppressor homologue functions in cellular adhesion. 2002, Pubmed
Heasman, Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. 1994, Pubmed , Xenbase
Hecht, Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro. 1999, Pubmed
Hecht, The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. 2000, Pubmed , Xenbase
Hinck, Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin. 1994, Pubmed
Huber, The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. 2001, Pubmed
Huber, A specific domain in alpha-catenin mediates binding to beta-catenin or plakoglobin. 1997, Pubmed
Huber, The cadherin cytoplasmic domain is unstructured in the absence of beta-catenin. A possible mechanism for regulating cadherin turnover. 2001, Pubmed
Jho, A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. 1999, Pubmed
Kolligs, Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. 1999, Pubmed
Korswagen, Distinct beta-catenins mediate adhesion and signalling functions in C. elegans. 2000, Pubmed
Koslov, Alpha-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with beta-catenin. 1997, Pubmed
Lickert, Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. 2000, Pubmed
Loureiro, Roles of Armadillo, a Drosophila catenin, during central nervous system development. 1998, Pubmed
McCrea, Induction of a secondary body axis in Xenopus by antibodies to beta-catenin. 1993, Pubmed , Xenbase
Orsulic, E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. 1999, Pubmed
Perego, Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons. 2000, Pubmed
Piedra, Regulation of beta-catenin structure and activity by tyrosine phosphorylation. 2001, Pubmed
Pokutta, Structure of the dimerization and beta-catenin-binding region of alpha-catenin. 2000, Pubmed
Polakis, The oncogenic activation of beta-catenin. 1999, Pubmed
Rimm, Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. 1995, Pubmed
Roura, Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. 1999, Pubmed
Rubinfeld, Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. 1996, Pubmed
Sanson, Uncoupling cadherin-based adhesion from wingless signalling in Drosophila. 1996, Pubmed
Shtutman, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. 1999, Pubmed
Staal, Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. 2002, Pubmed
Stappert, A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. 1994, Pubmed
Suh, Translocation of beta-catenin into the nucleus independent of interactions with FG-rich nucleoporins. 2003, Pubmed , Xenbase
Tago, Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. 2000, Pubmed , Xenbase
Tutter, Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. 2001, Pubmed
Vasioukhin, Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. 2001, Pubmed
Winston, The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. 1999, Pubmed